Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Inserm Transfert Initiative

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 22
Average round size
info
The average size of a deal this fund participated in
$18M
Portfolio companies 15
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.32
Exits 4
Key employees 1
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Medical
  • Therapeutics
  • Health Care
  • Medical Device
Summary

The leading representative office of defined VC is situated in the Paris. The company was established in Europe in France.

Considering the real fund results, this VC is 14 percentage points less often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2019. The top activity for fund was in 2015. This Inserm Transfert Initiative works on 17 percentage points less the average amount of lead investments comparing to the other organizations.

Besides them, we counted 1 critical employee of this fund in our database.

Among the most successful fund investment fields, there are Biopharma, Health Care. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 3 of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - France. Among the various public portfolio startups of the fund, we may underline ENYO Pharma, ScreenCell, Hemarina

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Inserm Transfert Initiative, startups are often financed by Versant Ventures, OrbiMed, AGORANOV. The meaningful sponsors for the fund in investment in the same round are Bpifrance, Versant Ventures, OrbiMed. In the next rounds fund is usually obtained by Auriga Partners, Versant Ventures, OrbiMed.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Inserm Transfert Initiative:
Typical Co-investors
Inserm Transfert Initiative is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Inserm Transfert Initiative:

Funds with similar focus

Funds from France
Funds with similar focus located in France:
Funds with the same geo focus
Funds with similar geography of portfolio companies:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
10X Investments Gauteng, NA - South Africa, South Africa
Angeles Investors -
Earthlink Atlanta, Georgia, United States
Emerisque Brands -
Horse Angels -
Stroud Companies Dallas, Texas, United States
University of Auckland Inventors Fund -
Venturra Discovery Indonesia, Jakarta, Jakarta Raya
Xandas New Media Ventures Italy, Lombardia, Milano

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

VectivBio

Biotechnology
Health Care
Medical
$35M08 Jan 2020 Basel, Basel-City, Switzerland

Therachon

Biotechnology
Medical
Therapeutics
$60M09 Aug 2018 Basel, Basel-City, Switzerland

BIOMODEX

3D Printing
Health Care
Medical Device
$15M08 Jun 2018 Ile-de-France

ENYO Pharma

Biopharma
Biotechnology
Medical
$47M04 Jun 2018 Lyon, Auvergne-Rhône-Alpes, France

Step Pharma

Biotechnology
Pharmaceutical
$17M21 Nov 2017 France, Ile-de-France

Therachon

Biotechnology
Medical
Therapeutics
$5M06 Jan 2017 Basel, Basel-City, Switzerland

BIOMODEX

3D Printing
Health Care
Medical Device
$3M11 Apr 2016 Paris, Ile-de-France, France

Inception IBD

Biotechnology
Drug Discovery
Health Care
Medical
$14M10 Dec 2015 San Diego, California, United States

Therachon

Biotechnology
Medical
Therapeutics
$35M30 Sep 2015 Basel, Basel-City, Switzerland

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Inserm Transfert Initiative?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 22
Average round size 18M
Peak activity year 2015
Lead investments 1
Follow on index 0.32
Exits 4
Group Appearance index 0.95

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

VectivBio

Biotechnology
Health Care
Medical
$35M08 Jan 2020 Basel, Basel-City, Switzerland

Therachon

Biotechnology
Medical
Therapeutics
$60M09 Aug 2018 Basel, Basel-City, Switzerland

BIOMODEX

3D Printing
Health Care
Medical Device
$15M08 Jun 2018 Ile-de-France

ENYO Pharma

Biopharma
Biotechnology
Medical
$47M04 Jun 2018 Lyon, Auvergne-Rhône-Alpes, France

Step Pharma

Biotechnology
Pharmaceutical
$17M21 Nov 2017 France, Ile-de-France

Therachon

Biotechnology
Medical
Therapeutics
$5M06 Jan 2017 Basel, Basel-City, Switzerland

BIOMODEX

3D Printing
Health Care
Medical Device
$3M11 Apr 2016 Paris, Ile-de-France, France

Inception IBD

Biotechnology
Drug Discovery
Health Care
Medical
$14M10 Dec 2015 San Diego, California, United States

Therachon

Biotechnology
Medical
Therapeutics
$35M30 Sep 2015 Basel, Basel-City, Switzerland
Crunchbase icon

Content report

The following text will be sent to our editors: